Stuart A. Arbuckle
2013
In 2013, Stuart A. Arbuckle earned a total compensation of $4.8M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $630,000 |
|---|---|
| Option Awards | $3,077,513 |
| Salary | $553,846 |
| Stock Awards | $544,988 |
| Other | $12,675 |
| Total | $4,819,022 |
Arbuckle received $3.1M in option awards, accounting for 64% of the total pay in 2013.
Arbuckle also received $630K in non-equity incentive plan, $553.8K in salary, $545K in stock awards and $12.7K in other compensation.
Rankings
In 2013, Stuart A. Arbuckle's compensation ranked 1,347th out of 12,286 executives tracked by ExecPay. In other words, Arbuckle earned more than 89.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,347 out of 12,286 | 89th |
Division Manufacturing | 433 out of 4,612 | 91st |
Major group Chemicals And Allied Products | 118 out of 1,462 | 92nd |
Industry group Drugs | 78 out of 1,156 | 93rd |
Industry Pharmaceutical Preparations | 69 out of 890 | 92nd |
Source: SEC filing on April 29, 2016.
Arbuckle's colleagues
We found four more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2013.